1. Nutrients in the Chemoprevention of Prostate Cancer: Current and Future Prospects
- Author
-
Nagi B. Kumar and Karen Besterman-Dahan
- Subjects
Oncology ,medicine.medical_specialty ,High prevalence ,business.industry ,Cancer chemoprevention ,Cancer ,Hematology ,General Medicine ,030204 cardiovascular system & hematology ,Pharmacology ,Isoflavones ,medicine.disease ,Long latency ,03 medical and health sciences ,Prostate cancer ,chemistry.chemical_compound ,0302 clinical medicine ,chemistry ,Internal medicine ,medicine ,Phytoestrogens ,030212 general & internal medicine ,business - Abstract
Background External factors such as diet and lifestyle may be important in the etiology of invasive prostate cancer. Specific features of prostate cancer, including high prevalence, long latency, and significant mortality and morbidity, provide the opportunities for chemoprevention. Methods The authors examine the experimental and epidemiological data demonstrating the chemopreventive activity, safety, and toxicity of chronic administration of these specific nutrients as chemopreventive agents in prostate cancer. Results Several nutrients have been identified as agents that inhibit mutagenesis and hyperproliferation or induce apoptosis or differentiation, which are critical characteristics for chemoprevention. Successful chemopreventive strategies require well-characterized agents, suitable cohorts, and reliable intermediate biomarkers of cancer for evaluating efficacy. Phytoestrogens/isoflavones, vitamins D and E, selenium, and lycopene have been identified as promising nutrients in the role of chemoprevention of prostate cancer. Conclusions Clinical studies to evaluate the safety and effectiveness of these agents as future prospects in cancer chemoprevention, both individually and in combination, are warranted.
- Published
- 1999